Literature DB >> 12734777

Effect of losartan on insulin plasma concentrations and LPL activity in adipose tissue of hypertensive rats.

T Saranteas1, E Lolis, C Mourouzis, A Potamianou, C Tesseromatis, D Varonos.   

Abstract

The aim of this study is to determine the effect of losartan on insulin and angiotensin II (Ang II) concentrations in plasma as well as on lipoprotein lipase activity (LPL) and angiotensin II content in the adipose tissue of hypertensive rats. Fifty male rats were divided in five groups. Group A served as controls. Group B underwent renal artery stenosis. Group C were administered losartan (10 mg/kg/day) per os, while rats in group D were submitted to renal artery stenosis and were treated with losartan as above. Group E was used as sham-operated control. The animals were sacrificed at day 21. Blood samples were collected, and perirenal adipose tissue was isolated. Furthermore, adrenal's were removed and their relative weight (adrenal weight/body weight) was used as an index of sympathetic stimulation. According to our results, renovascular hypertension resulted in lower insulin concentrations and higher Ang II content in plasma. In hypertensive rats, LPL activity was decreased, while the adrenals' relative weight was elevated. On the other hand, losartan administration resulted in normalization of insulin concentrations in plasma and adrenals' relative weight, with consequent up regulation of LPL activity in adipose tissue. In conclusion, renovascular hypertension interferes in lipid metabolism by reducing LPL activity in adipose tissue, while losartan administration reverses this effect by enhancing insulin release and reducing sympathetic nervous system (SNS) stimulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734777     DOI: 10.1055/s-2003-39071

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  2 in total

1.  Lipid kinetics in obese patients undergoing laparoscopy. The impact of cortisol inhibition by etomidate.

Authors:  T Saranteas; V Voukena; N Zotos; J Stranomiti; A Kondadaki; A Tachmintzi; C Pantos; C Tesseromatis; V Dimitriou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jul-Sep       Impact factor: 2.441

2.  Preventive effect of Ibrolipim on suppressing lipid accumulation and increasing lipoprotein lipase in the kidneys of diet-induced diabetic minipigs.

Authors:  Yi Liu; Zong Bao Wang; Wei Dong Yin; Qin Kai Li; Man Bo Cai; Jian Yu; Hong Guang Li; Chi Zhang; Xiu Hong Zu
Journal:  Lipids Health Dis       Date:  2011-07-16       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.